Skip to main content

Table 2 Blood levels of MUC1 and VEGF mRNA in NSCLC patients and BLD patients at two sampling time points

From: Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer

Patient

N

MUC1 mRNA

VEGF mRNA

B0

B4w

P value

B0

B4w

P value

Median

Range

Median

Range

Median

Range

Median

Range

NSCLC

66

5.95

1.16-17.56

4.46

0.64-12.45

0.027

4.88

1.07-15.32

3.82

0.88-13.84

0.035

BLD

55

2.06

0.32-4.17

   

1.75

0.41-3.28

   

P value

 

<0.001

 

0.002*

  

<0.001

 

0.003*

  
  1. *NSCLC patients at B4w compared with BLD patients.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us